Session III: Short Talks (Continued) & Therapeutic Targeting of Cellular Mechanisms
2:30 PM
Substrate-Derived Peptides for Selective Covalent Inhibition of Protein Tyrosine Kinases
Minhee Lee, Columbia University
2:32 PM
Development of Crosslinked Helix Dimer Protein Degraders
Joseph Ongkingco, New York University
2:34 PM
Towards the AI-Guided Development of Novel Living-Yeast Biosensors: a Platform for the Prediction, High-throughput Synthesis, and Screening of Novel G-Protein Coupled Receptors
Adriana Di Nanni, PhD, Columbia University
2:36 PM
Autophagy–Lysosome Targeting Heterobifunctional Chimeras as Therapeutic Approaches
Xiaoqing Han, PhD, Merck
2:38 PM
Inhibiting the Folding Activity of Human Hsp70s with Selective Peptidomimetics
Gideon Yawson, New York University
2:40 PM
Development of Minimalistic Radical-Trapping Probes for Labeling Protein Thiyl Radicals
Ruocheng Yu, PhD, Harvard University
2:50 PM
Kinetic Selectivity of Kinase Inhibitors
Madeeha Ali, PhD, Stony Brook University
3:00 PM
Elucidation of the Mechanism-of-Action of Empirically-Isolated, Breakthrough Folding-Corrector Drugs via Cryo-EM Reconstruction of Protein Folding Intermediates
Andrew Paige, Columbia University